Literature DB >> 18834985

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis.

A Blum1, R Shamburek.   

Abstract

Statins have been demonstrated to significantly affect the prognosis and outcome of patients with risk factors to atherosclerosis (in primary and secondary prevention trials). Several clinical and recently basic studies have suggested an extra-beneficial effect of the statins in the prevention of atherosclerosis and coronary artery disease. These studies showed that statins may affect the cardiovascular system beyond their effect on the lipid profile, and it was suggested that they affect the immunological system and vascular inflammation. Many of the beneficial pleiotropic effects of statins occur as a result of modulated endothelial function and reduced inflammatory processes. Attempting to understand these properties of statins is an exciting field of research that will also improve our understanding of vascular biology in health and disease, and thus enable the better use of this drug class in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834985     DOI: 10.1016/j.atherosclerosis.2008.08.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  86 in total

1.  Statin therapy for heart failure: to prescribe or not?

Authors:  Xian-Sheng Huang; Shui-Ping Zhao
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Statin adjunctive therapy shortens the duration of TB treatment in mice.

Authors:  Noton K Dutta; Natalie Bruiners; Michael L Pinn; Matthew D Zimmerman; Brendan Prideaux; Véronique Dartois; Maria L Gennaro; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2016-02-21       Impact factor: 5.790

Review 3.  Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Authors:  Alain Li-Wan-Po; Bart Loeys; Peter Farndon; David Latham; Caroline Bradley
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

4.  Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.

Authors:  Stacy P Ardoin; Laura Eve Schanberg; Christy I Sandborg; Huiman X Barnhart; Greg W Evans; Eric Yow; Kelly L Mieszkalski; Norman T Ilowite; Anne Eberhard; Lisa F Imundo; Yuki Kimura; Deborah Levy; Emily von Scheven; Earl Silverman; Suzanne L Bowyer; L Punaro; Nora G Singer; David D Sherry; Deborah K McCurdy; Marissa Klein-Gitelman; Carol Wallace; Richard M Silver; Linda Wagner-Weiner; Gloria C Higgins; Hermine I Brunner; Lawrence Jung; Jennifer B Soep; Ann M Reed; Susan D Thompson
Journal:  Ann Rheum Dis       Date:  2013-02-22       Impact factor: 19.103

5.  Statin use in giant cell arteritis: a retrospective study.

Authors:  Jean Schmidt; Tanaz A Kermani; Francesco Muratore; Cynthia S Crowson; Eric L Matteson; Kenneth J Warrington
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

6.  Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.

Authors:  Madhuvanthi A Kandadai; Jason Meunier; Christopher J Lindsell; George J Shaw; Mitchell S V Elkind
Journal:  Curr Neurovasc Res       Date:  2012-08       Impact factor: 1.990

Review 7.  You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging.

Authors:  Douglas R Seals; Rachelle E Kaplon; Rachel A Gioscia-Ryan; Thomas J LaRocca
Journal:  Physiology (Bethesda)       Date:  2014-07

8.  The effect and molecular mechanism of statins on the expression of human anti-coagulation genes.

Authors:  Sheng-Nan Chang; Cho-Kai Wu; Ling-Ping Lai; Fu-Tien Chiang; Juey-Jen Hwang; Chia-Ti Tsai
Journal:  Cell Mol Life Sci       Date:  2019-05-03       Impact factor: 9.261

Review 9.  Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis.

Authors:  Linda Björkhem-Bergman; Peter Bergman; Jan Andersson; Jonatan D Lindh
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.

Authors:  Benjaporn Buranrat; Wanwisa Suwannaloet; Jarinyaporn Naowaboot
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.